MedTrace Logo

Evaluation of Safety and Efficacy of Glaucoma Shunt (Aurolab Artificial Drainage Implant) in Refractory Glaucoma

NCT01401088 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2013-01-03

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of Aurolab Artificial Drainage Implant (AADI) on intraocular pressure reduction in patients with refractory glaucoma.

Conditions

Interventions

DEVICE

Artificial drainage implant

Artificial drainage implant is used for intra ocular pressure reduction in patient with refractory glaucoma

Sponsors & Collaborators

  • Aurolab

    lead OTHER

Principal Investigators

  • Dr. Prashanth Ranganath, MBBS., MS., · Aravind Eye Hospital, Madurai

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2013-11-30
Completion
2013-12-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01401088 on ClinicalTrials.gov